The American Society for Reproductive Medicine is pleased to announce the availability of a limited number of awards to support the travel of trainees who are presenting abstracts at the 2014 IFFS/ASRM conjoint meeting in Boston. These awards are made possible through the generous support of the ASRM Board of Directors and the ASRM Corporate Member Council. Congratulations to the 2013 Award Winners!
- 15 awards of $1,500 USD to trainee abstract presenters from the United States
- 15 awards of $2,000 USD to trainee abstract presenters from countries outside the United States*
- Must be an undergraduate, graduate, medical or allied health professions student, postdoctoral trainee, or clinical resident or fellow.
- Must be the first and presenting author of the abstract.
- Abstract must have been selected for oral or poster presentation in the ASRM 2014 Scientific Program.
- Applicants must check the box on the abstract submission site indicating their desire to be considered for an award.
- By June 1, 2014, applicants must submit a curriculum vitae, including current educational program, as a single electronic pdf file to email@example.com.
- Recipients will be notified by email by July 1, 2014.
- Payment will be made at the time of the Annual Meeting.
- Applications will be reviewed by the ASRM Research Committee.
- Selection will be based on scientific merit of the abstract and qualifications of the presenter.
- Questions regarding eligibility, application, payment, etc., should be directed to Dr. Andrew R. La Barbera, ASRM Scientific Director, at firstname.lastname@example.org.
**Residents of the following countries are NOT eligible for the international awards: Andorra, Aruba, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Bermuda, Brunei Darussalam, Canada, Cayman Islands, Channel Islands, China, Croatia, Curaçao, Cyprus, Czech Republic, Denmark, Equatorial Guinea, Estonia, Faeroe Islands, Finland, France, French Polynesia, Germany, Greece, Greenland, Guam, Hungary, Iceland, Ireland, Isle of Man, Israel, Italy, Japan, Korea, Kuwait, Liechtenstein, Luxembourg, Macao SAR, Malta, Monaco, Netherlands, New Caledonia, New Zealand, Northern Mariana Islands, Norway, Oman, Poland, Portugal, Puerto Rico, Qatar, Rep. St. Kitts and Nevis, San Marino, Saudi Arabia, Singapore, Sint Maarten, Slovak Republic, Slovenia, Spain, St. Martin, Sweden, Switzerland, The Hong Kong SAR, Trinidad and Tobago, Turks and Caicos Islands, United Arab Emirates, United Kingdom, Virgin Islands (U.S.)
Congratulations to the 2013 Award Winners:
O-5, Monday, October 14, 2013, 12:15 PM
ALTERNATIVELY SPLICED VARIANTS OF ANDROGEN RECEPTOR IN GRANULOSA CELLS: AN EPIGENETIC CAUSE OF OVARIAN HYPERANDROGENISM OF POLYCYSTIC OVARY SYNDROME
F.F. Wang1, J. X. Pan1, Y. Liu1, Q. Meng1, J. Z. Sheng2, H.F. Huang1. 1Women’s Hospital, School of Medicine, Zhejiang Universtiy, Hangzhou, Zhejiang, China; 2Department of Pathophysiology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
O-9, Monday, October 14, 2013, 4:40 PM
PREGNANCY OUTCOMES DECLINE IN RECIPIENTS OVER AGE 44: AN ANALYSIS OF 27,959 FRESH DONOR OOCYTE IN VITRO FERTILIZATION (IVF) CYCLES FROM THE SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY (SART)
J. S. Yeh1, R. G. Steward1, A. M. Dude1, A. A. Shah1, J. M. Goldfarb2, S. J. Muasher1. 1Division of Reproductive Endocrinology and Infertility, Duke University Medical Center, Durham, NC; 2University Hospitals Fertility Center, Beachwood, OH.
O-36, Monday, October 14, 2013, 4:15 PM
DELETERIOUS IMPACT OF PROPOFOL ON IN VITRO FERTILIZATION. A PROSPECTIVE RANDOMIZED TRIAL
M. Zitta, A. Mata, G. Santiago, M. H. Gómez, C. A. Sánchez Sarmiento, C. Avendaño. Nascentis -Especialistas en Fertilidad, Córdoba, Argentina.
O-130, Monday, October 14, 2013, 5:45 PM
HIGHER ANDROGEN AND ESTROGEN OUTPUT AND LESS FOLLICULAR ATRESIA CAN BE INDUCED IN HEALTHY OVARIES BY CULTURING THEM WITH SERA FROM PCOS PATIENTS: IS PCOS REALLY OF INTRAOVARIAN ORIGIN?
O. Oktem1,2, Y. Guzel2, C. Taskiran2, U. Ince3, E. Palaoglu4, B. Urman1,2. 1Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey; 2Women’s Health Unit, American Hospital, Turkey; 3Pathology, Acibadem University, Istanbul, Turkey; 4Clinical Laboratory, American Hospital, Istanbul, Turkey.
O-139, Monday, October 14, 2013, 4:00 PM
PATIENTS QUALIFYING FOR SINGLE EMBRYO TRANSFER (SET) HAVE EXCELLENT CRYO-AUGMENTED CUMULATIVE ONGOING PREGNANCY RATES AND LOW MULTIPLE BIRTH RATES
J. Kresowik, A. Sparks, G. Ryan, E. Duran, B. Van Voorhis. Obstetrics & Gynecology, REI Division, University of Iowa, Iowa City, IA.
O-147, Monday, October 14, 2013, 4:00 PM
PRE-CHEMOTHERAPY LEVELS OF FOLLICLE STIMULATING HORMONE AND ANTI-MULLERIAN HORMONE PREDICT TIME TO RETURN OF OVARIAN FUNCTION IN YOUNG BREAST CANCER PATIENTS
C. Haunschild1, M. Sammel2, K. Chung3, A. DeMichele4, H. I. Su1. 1Reproductive Endocrinology and Infertility, University of California, San Diego, La Jolla, CA; 2Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA; 3Reproductive Endocrinology and Infertility, University of Southern California, Los Angeles, CA; 4Reproductive Endocrinology and Infertility, University of Pennsylvania School of Medicine, Philadelphia, PA.
O-148, Monday, October 14, 2013, 4:15 PM
ANTI-VEGF ANTIBODY TREATMENT PROTECTS AGAINST ALKYLATING CHEMOTHERAPY INDUCED GONADOTOXICITY IN MICE
H. Cakmak1, A. M. Zamah1, T. Ozawa2, M. D. Prados2, M. I. Cedars1, M. P. Rosen1. 1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA; 2Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA.
O-168, Tuesday, October 15, 2013, 12:30 PM
COMPARISON OF MONTELUKAST AND CABERGOLINE FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS): IN AN EXPERIMENTAL RAT MODEL.
L. Akman1, G. Sahin2, O. Erbas3, H. Aktug4, A. Akdogan2, E. N. Tavmergen Goker1,2. 1Obstetrics and Gynecology, Ege University Medical School, Izmir, Turkey; 2Family Planning and Infertility Research and Treatment Center, Ege University, Izmir, Turkey; 3Physiology, Ege University Medical School, Izmir, Turkey; 4Histology and Embrylogy, Ege University Medical School, Izmir, Turkey.
O-169, Tuesday, October 15, 2013, 4:00 PM
SILDENAFIL PREVENTS APOPTOSIS OF FIRST TRIMESTER TROPHOBLAST CELLS EXPOSED TO ENVIRONMENTAL STRESS
J. M. Bolnick1, B. A. Kilburn1, M. Singh1, M. P. Diamond2, M. Hertz1, D. R. Armant1,3. 1Ob/Gyn, Wayne State University, Detroit, MI; 2Ob/Gyn, Georgia Regents University, Athens, GA; 3PRAE, NICHD, NIH, Bethesda, MD.
O-172, Tuesday, October 15, 2013, 5:00 PM
A MOUSE MODEL FOR FRAGILE X- ASSOCIATED PRIMARY OVARIAN INSUFFICIENCY
E. Mok-Lin1, M. Ascano, Jr.2, Z. Rosenwaks1, T. Tuschl2, Z. Williams3. 1The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, NY; 2Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY; 3Department of Obstetrics & Gynecology and Womens Health, The Albert Einstein College of Medicine, Bronx, NY.
O-173, Tuesday, October 15, 2013, 5:20 PM
DEFINING DOSE-RESPONSE OF COPPER SURFACE AREA ON SPERM MOTILITY. AN EVALUATION OF THE COPPER CONTAINED IN THE COPPER INTRAUTERINE DEVICE (Cu-IUD)
M. Gualtieri1, R. Steward2, M. Wilson3, R. Paulson1, D. Mishell2. 1Reproductive Endocrinology and Infertility, University of Southern California, Los Angeles, CA; 2Obstetrics and Gynecology, University of Southern California, Los Angeles, CA; 3Preventive Medicine, University of Southern California, Los Angeles, CA.
O-220, Tuesday, October 15, 2013, 5:15 PM
QUALITY OF LIFE AND SEXUAL FUNCTIONING IN CERVICAL CANCER SURVIVORS AFTER SURGERY AND RADIOTHERAPY
P. Kumbhaj, R. Sharma, A. R. Bhatnagar. Radiation Oncology, S.M.S Medical College, Jaipur, Rajasthan, India.
O-241, Tuesday, October 15, 2013, 5:00 PM
THE CLINICAL EFFECTIVENESS OF MODIFIED LAPAROSCOPIC FIMBRIOPLASTY FOR THE TREATMENT OF MINIMAL ENDOMETRIOSIS AND UNEXPLAINED INFERTILITY
S. E. Franjoine1, J. H. Liu1, C. Geng2, M. A. Bedaiwy1. 1Obstetrics and Gynecology, University Hospitals Case Medical Center, Cleveland, OH; 2Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH.
O-249, Tuesday, October 15, 2013, 5:00 PM
PERIODICITY IN THE LEVELS OF SERUM PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) IS A ROBUST PROGNOSTIC FACTOR FOR EMBRYO IMPLANTATION AND CLINICAL PREGNANCY OUTCOME IN CONVENTIONAL IVF CYCLES
B. N. Mehta1, N. M. Nath1, N. N. Chimote1, N. M. Chimote1. 1Biochemistry, Vaunshdhara Clinic and Assisted Conception Centre, Nagpur, Maharashtra, India; 2Biochemistry, Vaunshdhara Clinic and Assisted Conception Centre, Nagpur, Maharashtra, India; 3Embryology, Vaunshdhara Clinic and Assisted Conception Centre, Nagpur, Maharashtra, India; 4Reproductive Endocrinilogy, Vaunshdhara Clinic and Assisted Conception Centre, Nagpur, Maharashtra, India.
O-260, Tuesday, October 15, 2013, 5:45 PM
THE EFFECT OF LUTEAL PHASE SUPPORT WITH VAGINAL PROGESTRONE ON PREGNANCY RATES IN INTRAUTERINE INSEMINATION (IUI) CYCLES
M. Ghazizadeh Ahsaie, H. Rahmanpour, F. Davari Tanha, B. Hossein Rashidi. Veli-e-asr Reproductive Health and Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
O-262, Tuesday, October 15, 2013, 4:15 PM
EUPLOIDY IS NOT ASSOCIATED WITH BODY MASS INDEX (BMI) IN PATIENTS UNDERGOING ANEUPLOIDY SCREENING WITH TROPHECTODERM (TE) BIOPSY AND ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH)
K. N. Goldman, B. Hodes-Wertz, D. McCulloh, J. A. Grifo. Obstetrics and Gynecology, Reproductive Endocrinology and Infertility, New York University Langone Medical Center, New York, NY.
O-296, Tuesday, October 15, 2013, 4:45 PM
THE STATE OF INSURANCE MANDATES AND INTRACYTOPLASMIC SPERM INJECTION (ICSI) USE IN THE UNITED STATES
N. K. Banks1, J. M. Norian2, M. B. Henne3. 1National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; 2HRC Fertility, Pasadena, CA; 3Department of Defense Pharmacoeconomic Center, Fort Sam Houston, TX.
O-325, Wednesday, October 16, 2013, 11:15 AM
IN VITRO FERTILIZATION (IVF) WITH 23-CHROMOSOME PAIR PREIMPLANTATION GENETIC SCREENING (PGS) IS COST EFFECTIVE TO ACHIEVE A LIVE BIRTH COMPARED TO IVF ALONE FOR RECURRENT PREGNANCY LOSS (RPL)
N. Resetkova1, K. J. Tobler1, W. G. Kearns1,2, E. F. Werner1. 1Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD; 2Center for Preimplantation Genetics, LabCorp., Rockville, MD.
O-342, Wednesday, October 16, 2013, 4:45 PM
ORAL CONTRACEPTIVE (OCP) PRETREATMENT IS DETRIMENTAL FOR PREGNANCY OUTCOME IN POOR OVARIAN RESPONDERS (PORs) UNDERGOING IVF EMPLOYING THE LETROZOLE/ANTAGONIST (L/A) PROTOCOL
T. Kasapoglu1, M. Polat2, K. Boynukalin2, G. Bozdag1, H. Yarali1,2. 1Hacettepe University, Faculty of Medicine, Sihhiye, Ankara, Turkey; 2Anatolia IVF Center, Çankaya, Ankara, Turkey.
O-364, Wednesday, October 16, 2013, 4:15 PM
RESCUE KARYOTYPING: A NOVEL APPROACH FOR RETROSPECTIVE CYTOGENETIC ASSESSMENT WITH DNA EXTRACTED FROM ARCHIVED PARAFFIN-EMBEDDED MISCARRIAGE TISSUE
R. Kudesia1, M. Li2, J. Smith2, A. Patel2, Z. Williams1. 1Department of Obstetrics, Gynecology & Womens Health, Albert Einstein College of Medicine, Bronx, NY; 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
O-400, Wednesday, October 16, 2013, 5:15 PM
ENDOMETRIAL INFUSION OF HUMAN CHORIONIC GONADOTROPIN AT THE TIME OF BLASTOCYST EMBRYO TRANSFER (ET) DOES NOT IMPROVE CLINICAL OUTCOMES
K. H. Hong1,2, E. J. Forman1,2, M. D. Werner1,2, C. L. Hart1, A. D. Winslow1, R. T. Scott, Jr.1,2. 1Reproductive Endocrinology and Infertility, Robert Wood Johnson Medical School, Basking Ridge, NJ; 2Reproductive Medicine Associates of NJ, Basking Ridge, NJ.
O-404, Wednesday, October 16, 2013
SEMINAL PLASMA LIPID FINGERPRINTING AND ITS ASSOCIATION TO SEMEN OXIDATIVE STRESS AND SPERM NUCLEAR DNA FRAGMENTATION
P. Intasqui1, C. Bruna de Lima1, M. Nichi2, E. J. Pilau3, E. G. Lo Turco1, R. P. Bertolla1. 1Department of Surgery, Division of Urology, Human Reproduction Section, Sao Paulo Federal University, Sao Paulo, SP, Brazil; 2Department of Animal Reproduction, School of Veterinary Medicine, University of Sao Paulo, Sao Paulo, Brazil; 3Center for Exact Sciences, Deparment of Chemistry, Maringa State University, Maringa, Parana, Brazil.
O-413, Wednesday, October 16, 2013, 5:00 PM
ACTIVATOR PROTEIN 1 (AP-1) MEMBERS FOSL2 AND JUN ARE DIRECT TARGETS OF PROGESTERONE RECEPTOR AND CRITICAL FOR HUMAN ENDOMETRIAL STROMA CELL DECIDUALIZATION
E. C. Mazur1, Y. M. Vasquez2, E. Kovanci1, L. Jiang3, R. Chen3, F. J. DeMayo2. 1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX; 2Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX; 3Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
O-427, Wednesday, October 16, 2013, 4:30 PM
INCIDENCE AND CAUSES OF GENDER MISDIAGNOSIS IN PREIMPLANTATION GENETIC SCREENING
L. Guzman1,2, P. Colls3, X. Zheng3, E. Margiatto3, S. Munne3, J. Cohen3. 1Embryology Laboratorio, Grupo PRANOR, Lima, Peru; 2Reprogenetics Latinoamerica, Lima, Peru; 3Reprogenetics, Livingston, NJ.
O-442, Wednesday, October 16, 2013, 4:15 PM
EVIDENCE OF GNRH ANTAGONIST ESCAPE IN OBESE WOMEN: POTENTIAL EXPLANATION FOR THE HIGH ASSISTED REPRODUCTIVE TECHNOLOGY CANCELLATION RATE
L. W. Roth1, E. L. Bradshaw-Pierce2, A. A. Allshouse3, J. Chosich1, A. J. Polotsky1, N. Santoro1. 1Obstetrics and Gynecology, University of Colorado, Denver, Aurora, CO; 2Pharmaceutical Sciences, University of Colorado, Denver, Aurora, CO; 3Biostatistics and Informatics, University of Colorado, Denver, Aurora, CO.
O-472, Wednesday, October 16, 2013, 5:45 PM
ENCLOMIPHENE CITRATE VERESUS CLOMIPHENE CITRATE FOR OVULATION INDUCTION IN WOMEN WITH UNEXPLAINED INFERTILITY
P. Gupta, A. Kriplani. Obsterica Gynecology, AIIMS, New Delhi, Delhi, India.
O-475, Wednesday, October 16, 2013, 4:30 PM
PROTEOMIC ANALYSIS OF ARTERIAL CORD SERUM PROTEINS IN NEONATES BORN AFTER IN VITRO FERTILIZATION (IVF) WITH FRESH AND CRYOPRESERVED/THAWED EMBRYOS
J. Wang, N. Zhao, X. Liu, W. Chen, Y. Cui, J. Liu. The State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
P-65, Tuesday, October 15, 2013
EVALUATION OF NEUTRAL RED INFLUENCE ON THE DEVELOPMENT OF MACAQUE SECONDARY FOLLICLES IN 3-DIMENSIONAL CULTURE
D. L. Bulgarelli1, A. Y. Ting2, M. B. Zelinski2,3. 1Department of Obstetrics and Gynecology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Sao Paulo, Brazil; 2Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR; 3Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.
P-477, Wednesday, October 16, 2013
COMPARISON OF PREGNANT OUTCOMES OF THAWING BLASTOCYST ONE DAY BEFORE TRANSFER OR NOT
T. Li, X. Wang, C. Yue, C. Fang. Center for Reproductive Medicine, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
P-592, Wednesday, October 16, 2013
COMPARISON OF TINZAPARIN WITH ENOXAPARIN IN UNEXPLAINED RECURRENT MISCARRIAGE
S. Kayatas1, H. Yüksel1, A. Ertekin1, C. Cam1. 1Gynecology and Infertility, Istanbul, Turkey; 2Gynecology and Infertility, Istanbul, Turkey; 3Gynecology and Infertility, Istanbul, Turkey; 4Gynecology and Infertility, Istanbul, Turkey.